p53 transactivity during in vitro osteoblast differentiation in a rat osteosarcoma cell line
- 2 June 1999
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 25 (2) , 132-138
- https://doi.org/10.1002/(sici)1098-2744(199906)25:2<132::aid-mc8>3.0.co;2-2
Abstract
We previously demonstrated a correlation between wild‐type p53 expression and appearance of osteoblastic‐specific differentiation characteristics, as evidenced by basal osteocalcin gene expression in a mouse osteosarcoma tumor. The study reported here further explored the possibility of p53's having a distinct transcription‐activating role in bone differentiation, in addition to its proposed role in G1 arrest and apoptosis. ROS17/2.3 osteoblastic osteosarcoma cells were stably transfected with a plasmid containing wild‐type p53 binding sequences fused to the chloramphenicol acetyltransferase reporter gene. These cells were used to determine the transactivating role of p53 in regulation of osteocalcin gene expression. We chose two conditions under which osteocalcin expression is known to be upregulated: exposure of osteoblastic cells to differentiation‐promoting medium and to vitamin D3. Exposure of the transfected cells to differentiation‐promoting medium produced an increase in p53 transactivating activity correlating with the appearance of osteocalcin expression after about 1 wk. Vitamin D3 treatment resulted in upregulation of osteocalcin activity without a corresponding change in p53 transactivation activity or expression. In separate experiments, we tested whether changes in osteocalcin expression accompanied changes in p53 activity under conditions of downregulation of cell proliferation mediated by inhibition of DNA synthesis. Hydroxyurea treatment was used to inhibit DNA synthesis and produce growth arrest in osteoblastic cells. Inhibition of osteoblast cell proliferation was associated with a fourfold increase in p53 transactivating activity and a transient increase in osteocalcin steady‐state expression. These results demonstrated a close relationship between p53 and osteocalcin and suggested a regulatory role for wild‐type p53 in the control of basal osteocalcin gene expression in osteoblasts. Mol. Carcinog. 25:132–138, 1999.Keywords
This publication has 17 references indexed in Scilit:
- Increased bone formation in osteocalcin-deficient miceNature, 1996
- Induction of the growth inhibitor IGF-binding protein 3 by p53Nature, 1995
- p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrestCell, 1994
- Influence of DNA replication inhibition on expression of cell growth and tissue‐specific genes in osteoblasts and osteosarcoma cellsJournal of Cellular Biochemistry, 1994
- Dependence of induction of osteocalcin gene expression on the presence of wild‐type p53 in a murine osteosarcoma cell lineMolecular Carcinogenesis, 1993
- Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53Published by Elsevier ,1992
- Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 allelesCell, 1992
- Oncogenic forms of p53 inhibit p53-regulated gene expressionScience, 1992
- Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvaria cellsJournal of Cellular Physiology, 1990
- Rearrangement of the p53 gene in human osteogenic sarcomas.Proceedings of the National Academy of Sciences, 1987